meta-reg-snw-7019
Interacting subnets
| Subnetwork | Dataset | Score | p-value 1 | p-value 2 | p-value 3 | Size | Highlighted genes |
|---|---|---|---|---|---|---|---|
| int-snw-811 | wolf-screen-ratio-mammosphere-adherent | 0.932 | 2.10e-15 | 2.63e-03 | 4.19e-02 | 24 | 22 |
| reg-snw-7019 | wolf-screen-ratio-mammosphere-adherent | 0.848 | 4.36e-07 | 1.94e-03 | 3.85e-03 | 6 | 5 |
Genes (27)
| Gene Symbol | Entrez Gene ID | Frequency | wolf-screen-ratio-mammosphere-adherent gene score | Best subnetwork score | Degree | Transcription factor | wolf adherent-list Hits GI | wolf mammosphere no adherent-list Hits GI |
|---|---|---|---|---|---|---|---|---|
| TFAM | 7019 | 2 | 0.169 | 0.848 | 154 | TF | - | - |
| PSMA3 | 5684 | 90 | 0.533 | 0.815 | 238 | - | Yes | - |
| PSMA2 | 5683 | 112 | 1.093 | 1.106 | 108 | - | Yes | - |
| PSMB7 | 5695 | 118 | 0.982 | 0.934 | 90 | - | Yes | - |
| HNRNPC | 3183 | 108 | 1.812 | 0.973 | 181 | - | Yes | - |
| RRM1 | 6240 | 15 | 0.587 | 0.872 | 117 | - | Yes | - |
| PSMA1 | 5682 | 100 | 0.996 | 0.878 | 152 | - | Yes | - |
| OGDH | 4967 | 72 | 0.847 | 0.802 | 126 | - | Yes | - |
| RPSA | 3921 | 120 | 1.327 | 1.151 | 152 | - | Yes | - |
| PGD | 5226 | 89 | 1.201 | 1.106 | 152 | - | Yes | - |
| CALR | 811 | 38 | -0.418 | 0.932 | 79 | - | - | Yes |
| CAD | 790 | 91 | 0.807 | 0.973 | 400 | - | - | - |
| PSMD1 | 5707 | 86 | 0.836 | 0.830 | 118 | - | Yes | - |
| PSMD13 | 5719 | 56 | 0.848 | 0.801 | 114 | TF | Yes | - |
| EEF2 | 1938 | 64 | 0.890 | 1.043 | 301 | - | Yes | - |
| PSMD3 | 5709 | 100 | 0.986 | 1.106 | 201 | TF | Yes | - |
| RPS11 | 6205 | 62 | 0.993 | 1.113 | 175 | - | Yes | - |
| EFTUD2 | 9343 | 93 | 0.883 | 0.956 | 108 | - | Yes | - |
| PSMB2 | 5690 | 116 | 0.877 | 0.956 | 169 | - | Yes | - |
| TUBG1 | 7283 | 98 | 0.974 | 0.973 | 91 | - | Yes | - |
| PSMD11 | 5717 | 124 | 1.095 | 1.106 | 218 | TF | Yes | - |
| ACTB | 60 | 134 | 1.153 | 1.151 | 610 | - | Yes | - |
| ITGAV | 3685 | 39 | 0.556 | 0.949 | 37 | - | - | - |
| RAN | 5901 | 89 | 0.632 | 0.899 | 258 | - | Yes | - |
| HSPD1 | 3329 | 70 | 0.913 | 1.035 | 325 | - | Yes | - |
| PSMD6 | 9861 | 79 | 0.848 | 0.878 | 143 | TF | Yes | - |
| PSMC1 | 5700 | 51 | 0.840 | 1.018 | 137 | - | Yes | - |
Interactions (109)
| Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
|---|---|---|---|---|---|---|
| PSMA3 | 5684 | PSMB2 | 5690 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Mouse, IntAct_Yeast, INTEROLOG, MINT_Yeast, YeastHigh, Krogan_Core |
| PSMD11 | 5717 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastHigh, BioGrid, INTEROLOG |
| HNRNPC | 3183 | PSMA3 | 5684 | pp | -- | int.I2D: BioGrid |
| EEF2 | 1938 | PGD | 5226 | pp | -- | int.I2D: BioGrid_Yeast |
| PSMA1 | 5682 | PSMD13 | 5719 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: IntAct, YeastMedium, BioGrid, BioGrid_Yeast, IntAct_Yeast |
| PSMA1 | 5682 | PSMB2 | 5690 | pp | -- | int.Intact: MI:0915(physical association), MI:0914(association); int.I2D: HPRD, IntAct, IntAct_Mouse, IntAct_Yeast, INTEROLOG, BioGrid_Yeast, Krogan_Core, MINT_Yeast, YeastHigh; int.HPRD: yeast 2-hybrid |
| EEF2 | 1938 | HSPD1 | 3329 | pp | -- | int.I2D: YeastLow, YeastMedium |
| PSMA2 | 5683 | PSMD13 | 5719 | pp | -- | int.I2D: YeastLow |
| PSMD1 | 5707 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, MINT_Yeast, Krogan_Core |
| ACTB | 60 | HSPD1 | 3329 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, YeastLow |
| HSPD1 | 3329 | TFAM | 7019 | pd | < | reg.ITFP.txt: no annot |
| PSMB7 | 5695 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast |
| PSMA2 | 5683 | PSMB7 | 5695 | pp | -- | int.Intact: MI:0914(association); int.I2D: BCI, BioGrid, BioGrid_Yeast, BIND_Yeast, IntAct, Krogan_Core, MINT_Yeast, YeastLow, IntAct_Yeast |
| PSMD1 | 5707 | PSMD13 | 5719 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: IntAct, MINT_Yeast, BioGrid, BioGrid_Yeast, IntAct_Yeast, Krogan_Core |
| PSMC1 | 5700 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, MINT_Yeast, YeastHigh, Krogan_Core |
| PGD | 5226 | RAN | 5901 | pp | -- | int.I2D: YeastLow |
| ACTB | 60 | PSMD13 | 5719 | pp | -- | int.I2D: BioGrid_Yeast |
| PSMB7 | 5695 | PSMC1 | 5700 | pp | -- | int.I2D: BioGrid_Yeast |
| PSMA2 | 5683 | PSMD1 | 5707 | pp | -- | int.I2D: BioGrid_Yeast |
| PSMA3 | 5684 | PSMD13 | 5719 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: IntAct, BioGrid |
| PSMA2 | 5683 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
| RPSA | 3921 | PSMD11 | 5717 | pp | -- | int.I2D: IntAct_Yeast |
| PSMB2 | 5690 | PSMD13 | 5719 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
| CALR | 811 | PSMA3 | 5684 | pp | -- | int.I2D: BioGrid |
| ACTB | 60 | PSMB2 | 5690 | pp | -- | int.I2D: BioGrid_Yeast |
| ACTB | 60 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast |
| PSMC1 | 5700 | PSMD13 | 5719 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, MINT_Yeast, YeastHigh, BioGrid, IntAct_Yeast, Krogan_Core |
| PSMA1 | 5682 | PSMD6 | 9861 | pd | < | reg.ITFP.txt: no annot |
| PSMA1 | 5682 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, YeastMedium |
| CALR | 811 | RAN | 5901 | pp | -- | int.I2D: IntAct_Worm, BioGrid_Worm, BIND_Worm, CORE_2, MINT_Worm |
| PSMD3 | 5709 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastHigh, INTEROLOG |
| ACTB | 60 | PSMC1 | 5700 | pp | -- | int.I2D: BioGrid_Yeast |
| PSMD1 | 5707 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast |
| ACTB | 60 | EEF2 | 1938 | pp | -- | int.I2D: YeastLow, IntAct_Yeast |
| RAN | 5901 | RPS11 | 6205 | pp | -- | int.I2D: IntAct_Worm, BioGrid_Worm, BIND_Worm, MINT_Worm, NON_CORE |
| PSMA1 | 5682 | PSMA2 | 5683 | pp | -- | int.Intact: MI:0915(physical association), MI:0914(association); int.I2D: BioGrid_Worm, BioGrid_Yeast, BIND_Worm, CE_DATA, HPRD, IntAct, IntAct_Mouse, IntAct_Yeast, INTEROLOG, MINT_Worm, BioGrid, IntAct_Fly, IntAct_Worm, Krogan_Core, MINT_Yeast, YeastHigh; int.HPRD: yeast 2-hybrid |
| RPSA | 3921 | RAN | 5901 | pp | -- | int.I2D: IntAct_Worm, BioGrid_Worm, BIND_Worm, CORE_2, MINT_Worm |
| ACTB | 60 | RPSA | 3921 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct_Yeast, IntAct |
| ACTB | 60 | PSMA3 | 5684 | pp | -- | int.I2D: BioGrid, BioGrid_Yeast |
| OGDH | 4967 | PSMD13 | 5719 | pp | -- | int.I2D: YeastLow |
| OGDH | 4967 | PSMD6 | 9861 | pp | -- | int.I2D: YeastLow |
| EEF2 | 1938 | PSMA3 | 5684 | pp | -- | int.I2D: BioGrid |
| PSMA1 | 5682 | PSMB7 | 5695 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid_Yeast, IntAct, IntAct_Mouse, IntAct_Yeast, YeastLow, Krogan_Core, MINT_Yeast |
| ACTB | 60 | PSMA1 | 5682 | pp | -- | int.I2D: BioGrid_Yeast |
| EEF2 | 1938 | PSMD3 | 5709 | pp | -- | int.I2D: Krogan_NonCore |
| ACTB | 60 | CAD | 790 | pp | -- | int.I2D: IntAct_Yeast |
| OGDH | 4967 | PGD | 5226 | pp | -- | int.I2D: YeastLow |
| PGD | 5226 | PSMD11 | 5717 | pp | -- | int.I2D: YeastLow |
| PSMD3 | 5709 | TUBG1 | 7283 | pd | > | reg.ITFP.txt: no annot |
| PSMB7 | 5695 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast |
| PSMA3 | 5684 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, YeastLow |
| PSMC1 | 5700 | PSMD1 | 5707 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, Krogan_Core, MINT_Yeast |
| PSMD1 | 5707 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid, BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, IntAct, Krogan_Core |
| PSMA3 | 5684 | PSMD1 | 5707 | pp | -- | int.I2D: BioGrid, BioGrid_Yeast |
| ACTB | 60 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast |
| PSMA3 | 5684 | EFTUD2 | 9343 | pp | -- | int.I2D: BioGrid |
| HSPD1 | 3329 | PSMA3 | 5684 | pp | -- | int.I2D: BioGrid |
| PGD | 5226 | PSMD3 | 5709 | pp | -- | int.I2D: YeastLow |
| RAN | 5901 | TFAM | 7019 | pd | < | reg.ITFP.txt: no annot |
| PSMA3 | 5684 | PSMB7 | 5695 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Mouse, MINT_Yeast, YeastLow, Krogan_Core |
| PSMB2 | 5690 | PSMB7 | 5695 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid_Yeast, Krogan_Core, MINT_Yeast, YeastLow, IntAct |
| PSMD3 | 5709 | PSMD6 | 9861 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid_Worm, BioGrid_Yeast, BIND_Worm, CE_DATA, IntAct, IntAct_Yeast, MINT_Worm, MINT_Yeast, YeastHigh, BioGrid, BIND_Yeast, IntAct_Worm, INTEROLOG, Krogan_Core, MIPS |
| ACTB | 60 | RAN | 5901 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, NON_CORE |
| CAD | 790 | RAN | 5901 | pp | -- | int.I2D: IntAct_Yeast |
| ACTB | 60 | PSMD6 | 9861 | pp | -- | int.I2D: BioGrid_Yeast |
| PSMC1 | 5700 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, MINT_Yeast, BioGrid, IntAct_Yeast, Krogan_Core, YeastHigh |
| PSMB2 | 5690 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
| PSMB7 | 5695 | PSMD1 | 5707 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid_Yeast, IntAct |
| PSMA1 | 5682 | PSMA3 | 5684 | pp | -- | int.Intact: MI:0914(association), MI:0915(physical association); int.I2D: BioGrid_Worm, BioGrid_Yeast, CE_DATA, HPRD, IntAct, IntAct_Fly, IntAct_Mouse, IntAct_Worm, IntAct_Yeast, MINT_Worm, BioGrid, BioGrid_Fly, BIND_Fly, BIND_Yeast, FlyHigh, Krogan_Core, MINT_Fly, MINT_Yeast, YeastHigh, Yu_GoldStd; int.HPRD: in vitro |
| PSMA2 | 5683 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
| TFAM | 7019 | TUBG1 | 7283 | pd | > | reg.ITFP.txt: no annot |
| PSMD11 | 5717 | TUBG1 | 7283 | pd | > | reg.ITFP.txt: no annot |
| PSMC1 | 5700 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastHigh, INTEROLOG |
| PSMA1 | 5682 | PSMD1 | 5707 | pp | -- | int.I2D: BioGrid_Yeast |
| PSMA3 | 5684 | PSMC1 | 5700 | pp | -- | int.I2D: BioGrid_Yeast |
| ACTB | 60 | PSMB7 | 5695 | pp | -- | int.I2D: BioGrid_Yeast |
| OGDH | 4967 | PSMD3 | 5709 | pp | -- | int.I2D: YeastLow |
| PSMA2 | 5683 | PSMC1 | 5700 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Fly, YeastLow |
| CAD | 790 | PSMB2 | 5690 | pp | -- | int.I2D: BioGrid_Yeast |
| PSMB7 | 5695 | PSMD6 | 9861 | pd | < | reg.ITFP.txt: no annot |
| PSMB7 | 5695 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct |
| PSMD11 | 5717 | EFTUD2 | 9343 | pd | > | reg.ITFP.txt: no annot |
| OGDH | 4967 | PSMD11 | 5717 | pp | -- | int.I2D: YeastLow |
| CALR | 811 | ITGAV | 3685 | pp | -- | int.I2D: HPRD, BCI; int.HPRD: in vitro, in vivo |
| PSMB7 | 5695 | PSMD13 | 5719 | pd | < | reg.ITFP.txt: no annot |
| PSMD13 | 5719 | RRM1 | 6240 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
| RRM1 | 6240 | TFAM | 7019 | pd | < | reg.ITFP.txt: no annot |
| PSMA3 | 5684 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
| PSMB2 | 5690 | PSMD6 | 9861 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
| HSPD1 | 3329 | RPSA | 3921 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
| PSMA1 | 5682 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
| PSMA3 | 5684 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast |
| OGDH | 4967 | RAN | 5901 | pp | -- | int.I2D: YeastLow |
| HSPD1 | 3329 | OGDH | 4967 | pp | -- | int.I2D: YeastLow |
| EEF2 | 1938 | PSMD13 | 5719 | pp | -- | int.I2D: YeastLow |
| PSMB2 | 5690 | PSMD11 | 5717 | pd | < | reg.ITFP.txt: no annot |
| PSMB2 | 5690 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
| OGDH | 4967 | PSMC1 | 5700 | pp | -- | int.I2D: YeastLow |
| PSMA2 | 5683 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, YeastLow, BioGrid |
| PSMA1 | 5682 | PSMC1 | 5700 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct_Fly, YeastMedium, IntAct |
| PSMD11 | 5717 | PSMD13 | 5719 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, IntAct_Yeast, Krogan_Core, MINT_Yeast, Tarassov_PCA, YeastHigh, BioGrid, INTEROLOG |
| PSMD3 | 5709 | PSMD13 | 5719 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, MINT_Yeast, YeastHigh, BioGrid, BioGrid_Yeast, IntAct_Yeast, Krogan_Core |
| PSMD13 | 5719 | PSMD6 | 9861 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, BioGrid_Yeast, IntAct, IntAct_Yeast, MINT_Yeast, YeastHigh, Krogan_Core |
| RPSA | 3921 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
| PSMD11 | 5717 | RRM1 | 6240 | pd | > | reg.ITFP.txt: no annot |
| CAD | 790 | RPSA | 3921 | pp | -- | int.I2D: IntAct_Yeast |
| HNRNPC | 3183 | TFAM | 7019 | pd | < | reg.ITFP.txt: no annot |
| PSMB2 | 5690 | PSMC1 | 5700 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
| PSMA2 | 5683 | PSMA3 | 5684 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BCI, BioGrid, BioGrid_Yeast, IntAct, IntAct_Fly, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastHigh, BIND_Yeast, HPRD; int.HPRD: yeast 2-hybrid |
| PSMA1 | 5682 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
| PSMB2 | 5690 | PSMD1 | 5707 | pp | -- | int.I2D: BioGrid_Yeast |
| PSMA2 | 5683 | PSMB2 | 5690 | pp | -- | int.Intact: MI:0914(association); int.I2D: BCI, BioGrid, BioGrid_Yeast, IntAct, INTEROLOG, MINT_Yeast, YeastHigh, IntAct_Yeast, Krogan_Core |
Related GO terms (399)
| Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
|---|---|---|---|---|---|---|---|
| GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 1.77e-24 | 2.89e-20 | 6.750 | 13 | 23 | 73 |
| GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 3.76e-24 | 6.13e-20 | 6.673 | 13 | 23 | 77 |
| GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 6.08e-23 | 9.92e-19 | 6.385 | 13 | 23 | 94 |
| GO:0006521 | regulation of cellular amino acid metabolic process | 8.60e-22 | 1.40e-17 | 7.055 | 11 | 21 | 50 |
| GO:0000502 | proteasome complex | 5.21e-21 | 8.50e-17 | 6.841 | 11 | 22 | 58 |
| GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.03e-20 | 3.32e-16 | 6.677 | 11 | 24 | 65 |
| GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 2.03e-20 | 3.32e-16 | 6.677 | 11 | 22 | 65 |
| GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.89e-20 | 7.99e-16 | 6.570 | 11 | 24 | 70 |
| GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 9.42e-20 | 1.54e-15 | 6.490 | 11 | 24 | 74 |
| GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 2.03e-19 | 3.31e-15 | 6.395 | 11 | 25 | 79 |
| GO:0010467 | gene expression | 2.83e-19 | 4.62e-15 | 4.024 | 18 | 58 | 669 |
| GO:0042981 | regulation of apoptotic process | 3.89e-18 | 6.36e-14 | 5.586 | 12 | 26 | 151 |
| GO:0016071 | mRNA metabolic process | 6.90e-18 | 1.13e-13 | 5.139 | 13 | 34 | 223 |
| GO:0000209 | protein polyubiquitination | 1.71e-17 | 2.78e-13 | 5.841 | 11 | 21 | 116 |
| GO:0016070 | RNA metabolic process | 2.65e-17 | 4.32e-13 | 4.992 | 13 | 34 | 247 |
| GO:0034641 | cellular nitrogen compound metabolic process | 2.74e-17 | 4.47e-13 | 5.357 | 12 | 25 | 177 |
| GO:0000082 | G1/S transition of mitotic cell cycle | 3.13e-16 | 5.11e-12 | 5.470 | 11 | 33 | 150 |
| GO:0016032 | viral process | 6.21e-16 | 1.01e-11 | 4.070 | 15 | 55 | 540 |
| GO:0005829 | cytosol | 2.70e-15 | 4.41e-11 | 2.440 | 23 | 125 | 2562 |
| GO:0000278 | mitotic cell cycle | 1.31e-14 | 2.13e-10 | 4.303 | 13 | 52 | 398 |
| GO:0070062 | extracellular vesicular exosome | 4.62e-14 | 7.55e-10 | 2.402 | 22 | 98 | 2516 |
| GO:0022624 | proteasome accessory complex | 1.38e-13 | 2.25e-09 | 7.737 | 6 | 9 | 17 |
| GO:0005654 | nucleoplasm | 9.78e-13 | 1.60e-08 | 3.143 | 16 | 83 | 1095 |
| GO:0043066 | negative regulation of apoptotic process | 1.27e-12 | 2.07e-08 | 4.066 | 12 | 30 | 433 |
| GO:0005838 | proteasome regulatory particle | 6.58e-12 | 1.07e-07 | 7.977 | 5 | 7 | 12 |
| GO:0044281 | small molecule metabolic process | 1.27e-11 | 2.08e-07 | 2.901 | 16 | 57 | 1295 |
| GO:0005839 | proteasome core complex | 7.07e-11 | 1.15e-06 | 7.392 | 5 | 11 | 18 |
| GO:0016020 | membrane | 8.63e-11 | 1.41e-06 | 2.557 | 17 | 80 | 1746 |
| GO:0004298 | threonine-type endopeptidase activity | 1.28e-10 | 2.08e-06 | 7.240 | 5 | 11 | 20 |
| GO:0006915 | apoptotic process | 6.85e-10 | 1.12e-05 | 3.542 | 11 | 34 | 571 |
| GO:0019773 | proteasome core complex, alpha-subunit complex | 2.25e-07 | 3.67e-03 | 7.825 | 3 | 5 | 8 |
| GO:0044822 | poly(A) RNA binding | 4.54e-06 | 7.40e-02 | 2.487 | 10 | 50 | 1078 |
| GO:0005844 | polysome | 9.06e-06 | 1.48e-01 | 6.181 | 3 | 4 | 25 |
| GO:0005634 | nucleus | 7.33e-05 | 1.00e+00 | 1.172 | 18 | 131 | 4828 |
| GO:0051087 | chaperone binding | 1.23e-04 | 1.00e+00 | 4.942 | 3 | 6 | 59 |
| GO:0005515 | protein binding | 1.24e-04 | 1.00e+00 | 0.981 | 20 | 172 | 6127 |
| GO:0030234 | enzyme regulator activity | 2.03e-04 | 1.00e+00 | 6.539 | 2 | 3 | 13 |
| GO:0042176 | regulation of protein catabolic process | 3.12e-04 | 1.00e+00 | 6.240 | 2 | 3 | 16 |
| GO:0003924 | GTPase activity | 3.26e-04 | 1.00e+00 | 3.574 | 4 | 9 | 203 |
| GO:0006184 | GTP catabolic process | 4.42e-04 | 1.00e+00 | 3.458 | 4 | 9 | 220 |
| GO:0006414 | translational elongation | 4.74e-04 | 1.00e+00 | 4.285 | 3 | 11 | 93 |
| GO:0033574 | response to testosterone | 5.97e-04 | 1.00e+00 | 5.780 | 2 | 2 | 22 |
| GO:0043044 | ATP-dependent chromatin remodeling | 6.53e-04 | 1.00e+00 | 5.716 | 2 | 4 | 23 |
| GO:0006206 | pyrimidine nucleobase metabolic process | 7.11e-04 | 1.00e+00 | 5.655 | 2 | 2 | 24 |
| GO:0006611 | protein export from nucleus | 7.72e-04 | 1.00e+00 | 5.596 | 2 | 4 | 25 |
| GO:0019058 | viral life cycle | 8.81e-04 | 1.00e+00 | 3.979 | 3 | 10 | 115 |
| GO:0031492 | nucleosomal DNA binding | 9.70e-04 | 1.00e+00 | 5.432 | 2 | 4 | 28 |
| GO:0044267 | cellular protein metabolic process | 1.17e-03 | 1.00e+00 | 2.610 | 5 | 24 | 495 |
| GO:0031072 | heat shock protein binding | 1.35e-03 | 1.00e+00 | 5.195 | 2 | 2 | 33 |
| GO:0043234 | protein complex | 1.41e-03 | 1.00e+00 | 3.011 | 4 | 17 | 300 |
| GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 1.65e-03 | 1.00e+00 | 9.240 | 1 | 1 | 1 |
| GO:0002502 | peptide antigen assembly with MHC class I protein complex | 1.65e-03 | 1.00e+00 | 9.240 | 1 | 1 | 1 |
| GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex | 1.65e-03 | 1.00e+00 | 9.240 | 1 | 1 | 1 |
| GO:0048291 | isotype switching to IgG isotypes | 1.65e-03 | 1.00e+00 | 9.240 | 1 | 1 | 1 |
| GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 1.65e-03 | 1.00e+00 | 9.240 | 1 | 1 | 1 |
| GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity | 1.65e-03 | 1.00e+00 | 9.240 | 1 | 1 | 1 |
| GO:0070335 | aspartate binding | 1.65e-03 | 1.00e+00 | 9.240 | 1 | 1 | 1 |
| GO:0052066 | entry of symbiont into host cell by promotion of host phagocytosis | 1.65e-03 | 1.00e+00 | 9.240 | 1 | 1 | 1 |
| GO:2000425 | regulation of apoptotic cell clearance | 1.65e-03 | 1.00e+00 | 9.240 | 1 | 1 | 1 |
| GO:0004151 | dihydroorotase activity | 1.65e-03 | 1.00e+00 | 9.240 | 1 | 1 | 1 |
| GO:0019521 | D-gluconate metabolic process | 1.65e-03 | 1.00e+00 | 9.240 | 1 | 1 | 1 |
| GO:0004070 | aspartate carbamoyltransferase activity | 1.65e-03 | 1.00e+00 | 9.240 | 1 | 1 | 1 |
| GO:2000536 | negative regulation of entry of bacterium into host cell | 1.65e-03 | 1.00e+00 | 9.240 | 1 | 1 | 1 |
| GO:0002368 | B cell cytokine production | 1.65e-03 | 1.00e+00 | 9.240 | 1 | 1 | 1 |
| GO:0016887 | ATPase activity | 1.68e-03 | 1.00e+00 | 3.655 | 3 | 7 | 144 |
| GO:0050681 | androgen receptor binding | 1.79e-03 | 1.00e+00 | 4.992 | 2 | 4 | 38 |
| GO:0022627 | cytosolic small ribosomal subunit | 1.88e-03 | 1.00e+00 | 4.954 | 2 | 3 | 39 |
| GO:0005525 | GTP binding | 1.95e-03 | 1.00e+00 | 2.882 | 4 | 11 | 328 |
| GO:0005925 | focal adhesion | 3.02e-03 | 1.00e+00 | 2.708 | 4 | 18 | 370 |
| GO:0034683 | integrin alphav-beta3 complex | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 2 |
| GO:0070363 | mitochondrial light strand promoter sense binding | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 2 |
| GO:0045252 | oxoglutarate dehydrogenase complex | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 2 | 2 |
| GO:0034686 | integrin alphav-beta8 complex | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 2 |
| GO:0006407 | rRNA export from nucleus | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 2 |
| GO:0042824 | MHC class I peptide loading complex | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 2 |
| GO:0001846 | opsonin binding | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 2 |
| GO:1990430 | extracellular matrix protein binding | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 2 |
| GO:0061034 | olfactory bulb mitral cell layer development | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 2 |
| GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 2 |
| GO:0050748 | negative regulation of lipoprotein metabolic process | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 2 |
| GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 2 |
| GO:0019322 | pentose biosynthetic process | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 2 |
| GO:0005055 | laminin receptor activity | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 2 |
| GO:0034684 | integrin alphav-beta5 complex | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 2 |
| GO:0033108 | mitochondrial respiratory chain complex assembly | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 2 |
| GO:0007127 | meiosis I | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 2 |
| GO:0070409 | carbamoyl phosphate biosynthetic process | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 2 |
| GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 3.58e-03 | 1.00e+00 | 4.485 | 2 | 5 | 54 |
| GO:0042995 | cell projection | 4.84e-03 | 1.00e+00 | 4.262 | 2 | 6 | 63 |
| GO:0009263 | deoxyribonucleotide biosynthetic process | 4.96e-03 | 1.00e+00 | 7.655 | 1 | 1 | 3 |
| GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity | 4.96e-03 | 1.00e+00 | 7.655 | 1 | 1 | 3 |
| GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb | 4.96e-03 | 1.00e+00 | 7.655 | 1 | 1 | 3 |
| GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity | 4.96e-03 | 1.00e+00 | 7.655 | 1 | 1 | 3 |
| GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process | 4.96e-03 | 1.00e+00 | 7.655 | 1 | 1 | 3 |
| GO:0006458 | 'de novo' protein folding | 4.96e-03 | 1.00e+00 | 7.655 | 1 | 1 | 3 |
| GO:0006391 | transcription initiation from mitochondrial promoter | 4.96e-03 | 1.00e+00 | 7.655 | 1 | 1 | 3 |
| GO:0000056 | ribosomal small subunit export from nucleus | 4.96e-03 | 1.00e+00 | 7.655 | 1 | 1 | 3 |
| GO:0009051 | pentose-phosphate shunt, oxidative branch | 4.96e-03 | 1.00e+00 | 7.655 | 1 | 1 | 3 |
| GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor | 4.96e-03 | 1.00e+00 | 7.655 | 1 | 1 | 3 |
| GO:0030135 | coated vesicle | 4.96e-03 | 1.00e+00 | 7.655 | 1 | 1 | 3 |
| GO:0044205 | 'de novo' UMP biosynthetic process | 4.96e-03 | 1.00e+00 | 7.655 | 1 | 1 | 3 |
| GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 4.96e-03 | 1.00e+00 | 7.655 | 1 | 1 | 3 |
| GO:0055086 | nucleobase-containing small molecule metabolic process | 6.44e-03 | 1.00e+00 | 4.050 | 2 | 5 | 73 |
| GO:0005759 | mitochondrial matrix | 6.52e-03 | 1.00e+00 | 2.960 | 3 | 12 | 233 |
| GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 1 | 4 |
| GO:0000212 | meiotic spindle organization | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 1 | 4 |
| GO:0030686 | 90S preribosome | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 1 | 4 |
| GO:0006104 | succinyl-CoA metabolic process | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 1 | 4 |
| GO:0006543 | glutamine catabolic process | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 1 | 4 |
| GO:0000055 | ribosomal large subunit export from nucleus | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 1 | 4 |
| GO:0032369 | negative regulation of lipid transport | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 1 | 4 |
| GO:0051208 | sequestering of calcium ion | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 1 | 4 |
| GO:2000510 | positive regulation of dendritic cell chemotaxis | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 1 | 4 |
| GO:0006412 | translation | 6.68e-03 | 1.00e+00 | 2.948 | 3 | 15 | 235 |
| GO:0071013 | catalytic step 2 spliceosome | 7.51e-03 | 1.00e+00 | 3.936 | 2 | 7 | 79 |
| GO:0019083 | viral transcription | 7.88e-03 | 1.00e+00 | 3.900 | 2 | 8 | 81 |
| GO:0051414 | response to cortisol | 8.25e-03 | 1.00e+00 | 6.918 | 1 | 1 | 5 |
| GO:0038027 | apolipoprotein A-I-mediated signaling pathway | 8.25e-03 | 1.00e+00 | 6.918 | 1 | 1 | 5 |
| GO:0043248 | proteasome assembly | 8.25e-03 | 1.00e+00 | 6.918 | 1 | 1 | 5 |
| GO:0046696 | lipopolysaccharide receptor complex | 8.25e-03 | 1.00e+00 | 6.918 | 1 | 1 | 5 |
| GO:0005827 | polar microtubule | 8.25e-03 | 1.00e+00 | 6.918 | 1 | 1 | 5 |
| GO:0006734 | NADH metabolic process | 8.25e-03 | 1.00e+00 | 6.918 | 1 | 1 | 5 |
| GO:0030976 | thiamine pyrophosphate binding | 8.25e-03 | 1.00e+00 | 6.918 | 1 | 1 | 5 |
| GO:0005681 | spliceosomal complex | 8.26e-03 | 1.00e+00 | 3.865 | 2 | 3 | 83 |
| GO:0006415 | translational termination | 9.04e-03 | 1.00e+00 | 3.797 | 2 | 8 | 87 |
| GO:0050821 | protein stabilization | 9.86e-03 | 1.00e+00 | 3.732 | 2 | 2 | 91 |
| GO:0003688 | DNA replication origin binding | 9.89e-03 | 1.00e+00 | 6.655 | 1 | 1 | 6 |
| GO:0021860 | pyramidal neuron development | 9.89e-03 | 1.00e+00 | 6.655 | 1 | 1 | 6 |
| GO:0021695 | cerebellar cortex development | 9.89e-03 | 1.00e+00 | 6.655 | 1 | 1 | 6 |
| GO:0030957 | Tat protein binding | 9.89e-03 | 1.00e+00 | 6.655 | 1 | 4 | 6 |
| GO:0046134 | pyrimidine nucleoside biosynthetic process | 9.89e-03 | 1.00e+00 | 6.655 | 1 | 1 | 6 |
| GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex | 9.89e-03 | 1.00e+00 | 6.655 | 1 | 1 | 6 |
| GO:0050764 | regulation of phagocytosis | 9.89e-03 | 1.00e+00 | 6.655 | 1 | 1 | 6 |
| GO:0006356 | regulation of transcription from RNA polymerase I promoter | 9.89e-03 | 1.00e+00 | 6.655 | 1 | 2 | 6 |
| GO:0040020 | regulation of meiosis | 9.89e-03 | 1.00e+00 | 6.655 | 1 | 1 | 6 |
| GO:0005200 | structural constituent of cytoskeleton | 1.03e-02 | 1.00e+00 | 3.700 | 2 | 7 | 93 |
| GO:0051082 | unfolded protein binding | 1.07e-02 | 1.00e+00 | 3.670 | 2 | 6 | 95 |
| GO:0001649 | osteoblast differentiation | 1.07e-02 | 1.00e+00 | 3.670 | 2 | 6 | 95 |
| GO:0042921 | glucocorticoid receptor signaling pathway | 1.15e-02 | 1.00e+00 | 6.432 | 1 | 1 | 7 |
| GO:0001849 | complement component C1q binding | 1.15e-02 | 1.00e+00 | 6.432 | 1 | 1 | 7 |
| GO:0000028 | ribosomal small subunit assembly | 1.15e-02 | 1.00e+00 | 6.432 | 1 | 1 | 7 |
| GO:0010888 | negative regulation of lipid storage | 1.15e-02 | 1.00e+00 | 6.432 | 1 | 2 | 7 |
| GO:0000930 | gamma-tubulin complex | 1.15e-02 | 1.00e+00 | 6.432 | 1 | 1 | 7 |
| GO:0031994 | insulin-like growth factor I binding | 1.15e-02 | 1.00e+00 | 6.432 | 1 | 1 | 7 |
| GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 1.27e-02 | 1.00e+00 | 3.539 | 2 | 8 | 104 |
| GO:0033018 | sarcoplasmic reticulum lumen | 1.32e-02 | 1.00e+00 | 6.240 | 1 | 1 | 8 |
| GO:0006390 | transcription from mitochondrial promoter | 1.32e-02 | 1.00e+00 | 6.240 | 1 | 1 | 8 |
| GO:0070688 | MLL5-L complex | 1.32e-02 | 1.00e+00 | 6.240 | 1 | 1 | 8 |
| GO:0006554 | lysine catabolic process | 1.32e-02 | 1.00e+00 | 6.240 | 1 | 2 | 8 |
| GO:0006200 | ATP catabolic process | 1.33e-02 | 1.00e+00 | 2.581 | 3 | 14 | 303 |
| GO:0044183 | protein binding involved in protein folding | 1.48e-02 | 1.00e+00 | 6.070 | 1 | 1 | 9 |
| GO:0033690 | positive regulation of osteoblast proliferation | 1.48e-02 | 1.00e+00 | 6.070 | 1 | 1 | 9 |
| GO:0014075 | response to amine | 1.48e-02 | 1.00e+00 | 6.070 | 1 | 1 | 9 |
| GO:0008494 | translation activator activity | 1.48e-02 | 1.00e+00 | 6.070 | 1 | 1 | 9 |
| GO:0006228 | UTP biosynthetic process | 1.48e-02 | 1.00e+00 | 6.070 | 1 | 1 | 9 |
| GO:0031000 | response to caffeine | 1.48e-02 | 1.00e+00 | 6.070 | 1 | 2 | 9 |
| GO:0022417 | protein maturation by protein folding | 1.48e-02 | 1.00e+00 | 6.070 | 1 | 1 | 9 |
| GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.51e-02 | 1.00e+00 | 3.407 | 2 | 10 | 114 |
| GO:0030529 | ribonucleoprotein complex | 1.51e-02 | 1.00e+00 | 3.407 | 2 | 8 | 114 |
| GO:0043032 | positive regulation of macrophage activation | 1.64e-02 | 1.00e+00 | 5.918 | 1 | 1 | 10 |
| GO:0051604 | protein maturation | 1.64e-02 | 1.00e+00 | 5.918 | 1 | 1 | 10 |
| GO:0021756 | striatum development | 1.64e-02 | 1.00e+00 | 5.918 | 1 | 1 | 10 |
| GO:0005730 | nucleolus | 1.71e-02 | 1.00e+00 | 1.329 | 7 | 70 | 1684 |
| GO:0006098 | pentose-phosphate shunt | 1.81e-02 | 1.00e+00 | 5.780 | 1 | 3 | 11 |
| GO:0021846 | cell proliferation in forebrain | 1.81e-02 | 1.00e+00 | 5.780 | 1 | 1 | 11 |
| GO:0032727 | positive regulation of interferon-alpha production | 1.81e-02 | 1.00e+00 | 5.780 | 1 | 1 | 11 |
| GO:0048387 | negative regulation of retinoic acid receptor signaling pathway | 1.81e-02 | 1.00e+00 | 5.780 | 1 | 1 | 11 |
| GO:0045120 | pronucleus | 1.81e-02 | 1.00e+00 | 5.780 | 1 | 1 | 11 |
| GO:0051290 | protein heterotetramerization | 1.81e-02 | 1.00e+00 | 5.780 | 1 | 2 | 11 |
| GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.97e-02 | 1.00e+00 | 5.655 | 1 | 2 | 12 |
| GO:0006413 | translational initiation | 1.97e-02 | 1.00e+00 | 3.206 | 2 | 12 | 131 |
| GO:0021794 | thalamus development | 1.97e-02 | 1.00e+00 | 5.655 | 1 | 1 | 12 |
| GO:0009615 | response to virus | 2.00e-02 | 1.00e+00 | 3.195 | 2 | 6 | 132 |
| GO:0000790 | nuclear chromatin | 2.03e-02 | 1.00e+00 | 3.184 | 2 | 7 | 133 |
| GO:0010745 | negative regulation of macrophage derived foam cell differentiation | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 2 | 13 |
| GO:0001530 | lipopolysaccharide binding | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 2 | 13 |
| GO:0008266 | poly(U) RNA binding | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 1 | 13 |
| GO:0051131 | chaperone-mediated protein complex assembly | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 1 | 13 |
| GO:0003735 | structural constituent of ribosome | 2.26e-02 | 1.00e+00 | 3.100 | 2 | 8 | 141 |
| GO:0035267 | NuA4 histone acetyltransferase complex | 2.29e-02 | 1.00e+00 | 5.432 | 1 | 4 | 14 |
| GO:0043277 | apoptotic cell clearance | 2.29e-02 | 1.00e+00 | 5.432 | 1 | 1 | 14 |
| GO:0007020 | microtubule nucleation | 2.29e-02 | 1.00e+00 | 5.432 | 1 | 1 | 14 |
| GO:0071285 | cellular response to lithium ion | 2.29e-02 | 1.00e+00 | 5.432 | 1 | 2 | 14 |
| GO:0042026 | protein refolding | 2.45e-02 | 1.00e+00 | 5.333 | 1 | 2 | 15 |
| GO:0050431 | transforming growth factor beta binding | 2.45e-02 | 1.00e+00 | 5.333 | 1 | 1 | 15 |
| GO:0006261 | DNA-dependent DNA replication | 2.45e-02 | 1.00e+00 | 5.333 | 1 | 2 | 15 |
| GO:0010628 | positive regulation of gene expression | 2.50e-02 | 1.00e+00 | 3.020 | 2 | 4 | 149 |
| GO:0006457 | protein folding | 2.50e-02 | 1.00e+00 | 3.020 | 2 | 8 | 149 |
| GO:0042562 | hormone binding | 2.62e-02 | 1.00e+00 | 5.240 | 1 | 1 | 16 |
| GO:0071682 | endocytic vesicle lumen | 2.62e-02 | 1.00e+00 | 5.240 | 1 | 1 | 16 |
| GO:0050998 | nitric-oxide synthase binding | 2.62e-02 | 1.00e+00 | 5.240 | 1 | 1 | 16 |
| GO:0006103 | 2-oxoglutarate metabolic process | 2.62e-02 | 1.00e+00 | 5.240 | 1 | 1 | 16 |
| GO:0031589 | cell-substrate adhesion | 2.62e-02 | 1.00e+00 | 5.240 | 1 | 1 | 16 |
| GO:0031527 | filopodium membrane | 2.78e-02 | 1.00e+00 | 5.152 | 1 | 1 | 17 |
| GO:0010243 | response to organonitrogen compound | 2.78e-02 | 1.00e+00 | 5.152 | 1 | 2 | 17 |
| GO:0050919 | negative chemotaxis | 2.78e-02 | 1.00e+00 | 5.152 | 1 | 1 | 17 |
| GO:0008301 | DNA binding, bending | 2.78e-02 | 1.00e+00 | 5.152 | 1 | 1 | 17 |
| GO:0003746 | translation elongation factor activity | 2.78e-02 | 1.00e+00 | 5.152 | 1 | 3 | 17 |
| GO:0031528 | microvillus membrane | 2.78e-02 | 1.00e+00 | 5.152 | 1 | 1 | 17 |
| GO:0031258 | lamellipodium membrane | 2.78e-02 | 1.00e+00 | 5.152 | 1 | 2 | 17 |
| GO:0075733 | intracellular transport of virus | 2.78e-02 | 1.00e+00 | 5.152 | 1 | 2 | 17 |
| GO:0050870 | positive regulation of T cell activation | 2.78e-02 | 1.00e+00 | 5.152 | 1 | 1 | 17 |
| GO:0046718 | viral entry into host cell | 2.94e-02 | 1.00e+00 | 5.070 | 1 | 1 | 18 |
| GO:0017025 | TBP-class protein binding | 2.94e-02 | 1.00e+00 | 5.070 | 1 | 2 | 18 |
| GO:0006541 | glutamine metabolic process | 2.94e-02 | 1.00e+00 | 5.070 | 1 | 1 | 18 |
| GO:0031122 | cytoplasmic microtubule organization | 2.94e-02 | 1.00e+00 | 5.070 | 1 | 2 | 18 |
| GO:0070371 | ERK1 and ERK2 cascade | 2.94e-02 | 1.00e+00 | 5.070 | 1 | 1 | 18 |
| GO:0015949 | nucleobase-containing small molecule interconversion | 2.94e-02 | 1.00e+00 | 5.070 | 1 | 2 | 18 |
| GO:0000398 | mRNA splicing, via spliceosome | 3.02e-02 | 1.00e+00 | 2.873 | 2 | 12 | 165 |
| GO:0006259 | DNA metabolic process | 3.10e-02 | 1.00e+00 | 4.992 | 1 | 3 | 19 |
| GO:0050840 | extracellular matrix binding | 3.10e-02 | 1.00e+00 | 4.992 | 1 | 1 | 19 |
| GO:0048863 | stem cell differentiation | 3.10e-02 | 1.00e+00 | 4.992 | 1 | 1 | 19 |
| GO:0032733 | positive regulation of interleukin-10 production | 3.10e-02 | 1.00e+00 | 4.992 | 1 | 1 | 19 |
| GO:0055007 | cardiac muscle cell differentiation | 3.10e-02 | 1.00e+00 | 4.992 | 1 | 1 | 19 |
| GO:0034113 | heterotypic cell-cell adhesion | 3.10e-02 | 1.00e+00 | 4.992 | 1 | 1 | 19 |
| GO:0030866 | cortical actin cytoskeleton organization | 3.10e-02 | 1.00e+00 | 4.992 | 1 | 1 | 19 |
| GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 3.12e-02 | 1.00e+00 | 2.847 | 2 | 5 | 168 |
| GO:0009986 | cell surface | 3.17e-02 | 1.00e+00 | 2.103 | 3 | 9 | 422 |
| GO:0090398 | cellular senescence | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 1 | 20 |
| GO:0071364 | cellular response to epidermal growth factor stimulus | 3.42e-02 | 1.00e+00 | 4.847 | 1 | 1 | 21 |
| GO:0005790 | smooth endoplasmic reticulum | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 1 | 22 |
| GO:0030863 | cortical cytoskeleton | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 1 | 22 |
| GO:0036464 | cytoplasmic ribonucleoprotein granule | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 4 | 22 |
| GO:0007052 | mitotic spindle organization | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 2 | 22 |
| GO:0009897 | external side of plasma membrane | 3.65e-02 | 1.00e+00 | 2.724 | 2 | 4 | 183 |
| GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading | 3.74e-02 | 1.00e+00 | 4.716 | 1 | 2 | 23 |
| GO:0043236 | laminin binding | 3.74e-02 | 1.00e+00 | 4.716 | 1 | 1 | 23 |
| GO:0045787 | positive regulation of cell cycle | 3.74e-02 | 1.00e+00 | 4.716 | 1 | 1 | 23 |
| GO:0008305 | integrin complex | 3.74e-02 | 1.00e+00 | 4.716 | 1 | 1 | 23 |
| GO:0050766 | positive regulation of phagocytosis | 3.90e-02 | 1.00e+00 | 4.655 | 1 | 1 | 24 |
| GO:0000794 | condensed nuclear chromosome | 3.90e-02 | 1.00e+00 | 4.655 | 1 | 2 | 24 |
| GO:0042100 | B cell proliferation | 4.06e-02 | 1.00e+00 | 4.596 | 1 | 1 | 25 |
| GO:0001968 | fibronectin binding | 4.06e-02 | 1.00e+00 | 4.596 | 1 | 1 | 25 |
| GO:0042113 | B cell activation | 4.06e-02 | 1.00e+00 | 4.596 | 1 | 2 | 25 |
| GO:0017144 | drug metabolic process | 4.06e-02 | 1.00e+00 | 4.596 | 1 | 1 | 25 |
| GO:0032735 | positive regulation of interleukin-12 production | 4.06e-02 | 1.00e+00 | 4.596 | 1 | 1 | 25 |
| GO:0035987 | endodermal cell differentiation | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 1 | 26 |
| GO:0071556 | integral component of lumenal side of endoplasmic reticulum membrane | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 1 | 26 |
| GO:0019843 | rRNA binding | 4.38e-02 | 1.00e+00 | 4.485 | 1 | 3 | 27 |
| GO:0005737 | cytoplasm | 4.44e-02 | 1.00e+00 | 0.742 | 11 | 98 | 3976 |
| GO:0043022 | ribosome binding | 4.53e-02 | 1.00e+00 | 4.432 | 1 | 3 | 28 |
| GO:0019894 | kinesin binding | 4.53e-02 | 1.00e+00 | 4.432 | 1 | 1 | 28 |
| GO:0006099 | tricarboxylic acid cycle | 4.69e-02 | 1.00e+00 | 4.382 | 1 | 3 | 29 |
| GO:0003730 | mRNA 3'-UTR binding | 4.69e-02 | 1.00e+00 | 4.382 | 1 | 2 | 29 |
| GO:0001618 | virus receptor activity | 4.85e-02 | 1.00e+00 | 4.333 | 1 | 1 | 30 |
| GO:0034504 | protein localization to nucleus | 4.85e-02 | 1.00e+00 | 4.333 | 1 | 2 | 30 |
| GO:0061077 | chaperone-mediated protein folding | 5.01e-02 | 1.00e+00 | 4.285 | 1 | 2 | 31 |
| GO:0050661 | NADP binding | 5.17e-02 | 1.00e+00 | 4.240 | 1 | 1 | 32 |
| GO:0045335 | phagocytic vesicle | 5.32e-02 | 1.00e+00 | 4.195 | 1 | 2 | 33 |
| GO:0008380 | RNA splicing | 5.60e-02 | 1.00e+00 | 2.382 | 2 | 13 | 232 |
| GO:0097192 | extrinsic apoptotic signaling pathway in absence of ligand | 5.64e-02 | 1.00e+00 | 4.110 | 1 | 2 | 35 |
| GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway | 5.64e-02 | 1.00e+00 | 4.110 | 1 | 1 | 35 |
| GO:0042277 | peptide binding | 5.64e-02 | 1.00e+00 | 4.110 | 1 | 2 | 35 |
| GO:0034332 | adherens junction organization | 5.79e-02 | 1.00e+00 | 4.070 | 1 | 1 | 36 |
| GO:0034446 | substrate adhesion-dependent cell spreading | 5.79e-02 | 1.00e+00 | 4.070 | 1 | 2 | 36 |
| GO:0001895 | retina homeostasis | 5.79e-02 | 1.00e+00 | 4.070 | 1 | 1 | 36 |
| GO:0032755 | positive regulation of interleukin-6 production | 5.79e-02 | 1.00e+00 | 4.070 | 1 | 2 | 36 |
| GO:0005245 | voltage-gated calcium channel activity | 5.95e-02 | 1.00e+00 | 4.030 | 1 | 1 | 37 |
| GO:0051084 | 'de novo' posttranslational protein folding | 5.95e-02 | 1.00e+00 | 4.030 | 1 | 4 | 37 |
| GO:0018107 | peptidyl-threonine phosphorylation | 5.95e-02 | 1.00e+00 | 4.030 | 1 | 1 | 37 |
| GO:0045740 | positive regulation of DNA replication | 6.10e-02 | 1.00e+00 | 3.992 | 1 | 2 | 38 |
| GO:0070527 | platelet aggregation | 6.10e-02 | 1.00e+00 | 3.992 | 1 | 2 | 38 |
| GO:0021766 | hippocampus development | 6.26e-02 | 1.00e+00 | 3.954 | 1 | 4 | 39 |
| GO:0006096 | glycolytic process | 6.26e-02 | 1.00e+00 | 3.954 | 1 | 4 | 39 |
| GO:0042645 | mitochondrial nucleoid | 6.26e-02 | 1.00e+00 | 3.954 | 1 | 2 | 39 |
| GO:0032729 | positive regulation of interferon-gamma production | 6.26e-02 | 1.00e+00 | 3.954 | 1 | 2 | 39 |
| GO:0032092 | positive regulation of protein binding | 6.26e-02 | 1.00e+00 | 3.954 | 1 | 3 | 39 |
| GO:0007595 | lactation | 6.26e-02 | 1.00e+00 | 3.954 | 1 | 2 | 39 |
| GO:0043025 | neuronal cell body | 6.56e-02 | 1.00e+00 | 2.251 | 2 | 4 | 254 |
| GO:0045785 | positive regulation of cell adhesion | 6.57e-02 | 1.00e+00 | 3.882 | 1 | 5 | 41 |
| GO:0043195 | terminal bouton | 6.57e-02 | 1.00e+00 | 3.882 | 1 | 1 | 41 |
| GO:0017148 | negative regulation of translation | 6.57e-02 | 1.00e+00 | 3.882 | 1 | 1 | 41 |
| GO:0030521 | androgen receptor signaling pathway | 6.57e-02 | 1.00e+00 | 3.882 | 1 | 2 | 41 |
| GO:0005524 | ATP binding | 6.81e-02 | 1.00e+00 | 1.158 | 5 | 46 | 1354 |
| GO:0042110 | T cell activation | 6.88e-02 | 1.00e+00 | 3.813 | 1 | 3 | 43 |
| GO:0014070 | response to organic cyclic compound | 6.88e-02 | 1.00e+00 | 3.813 | 1 | 3 | 43 |
| GO:0010212 | response to ionizing radiation | 6.88e-02 | 1.00e+00 | 3.813 | 1 | 1 | 43 |
| GO:0007286 | spermatid development | 7.03e-02 | 1.00e+00 | 3.780 | 1 | 1 | 44 |
| GO:0005080 | protein kinase C binding | 7.03e-02 | 1.00e+00 | 3.780 | 1 | 1 | 44 |
| GO:0015030 | Cajal body | 7.19e-02 | 1.00e+00 | 3.748 | 1 | 2 | 45 |
| GO:0021762 | substantia nigra development | 7.34e-02 | 1.00e+00 | 3.716 | 1 | 1 | 46 |
| GO:0045665 | negative regulation of neuron differentiation | 7.34e-02 | 1.00e+00 | 3.716 | 1 | 2 | 46 |
| GO:0045727 | positive regulation of translation | 7.34e-02 | 1.00e+00 | 3.716 | 1 | 4 | 46 |
| GO:0019003 | GDP binding | 7.65e-02 | 1.00e+00 | 3.655 | 1 | 2 | 48 |
| GO:0031100 | organ regeneration | 7.96e-02 | 1.00e+00 | 3.596 | 1 | 4 | 50 |
| GO:0001948 | glycoprotein binding | 7.96e-02 | 1.00e+00 | 3.596 | 1 | 3 | 50 |
| GO:0016049 | cell growth | 7.96e-02 | 1.00e+00 | 3.596 | 1 | 1 | 50 |
| GO:0035690 | cellular response to drug | 7.96e-02 | 1.00e+00 | 3.596 | 1 | 2 | 50 |
| GO:0006091 | generation of precursor metabolites and energy | 8.11e-02 | 1.00e+00 | 3.567 | 1 | 3 | 51 |
| GO:0006986 | response to unfolded protein | 8.11e-02 | 1.00e+00 | 3.567 | 1 | 2 | 51 |
| GO:0005905 | coated pit | 8.11e-02 | 1.00e+00 | 3.567 | 1 | 2 | 51 |
| GO:0001669 | acrosomal vesicle | 8.11e-02 | 1.00e+00 | 3.567 | 1 | 1 | 51 |
| GO:0060041 | retina development in camera-type eye | 8.41e-02 | 1.00e+00 | 3.512 | 1 | 3 | 53 |
| GO:0003725 | double-stranded RNA binding | 8.57e-02 | 1.00e+00 | 3.485 | 1 | 6 | 54 |
| GO:0000226 | microtubule cytoskeleton organization | 8.72e-02 | 1.00e+00 | 3.458 | 1 | 3 | 55 |
| GO:0002039 | p53 binding | 8.72e-02 | 1.00e+00 | 3.458 | 1 | 7 | 55 |
| GO:0000932 | cytoplasmic mRNA processing body | 8.87e-02 | 1.00e+00 | 3.432 | 1 | 3 | 56 |
| GO:0002244 | hematopoietic progenitor cell differentiation | 9.17e-02 | 1.00e+00 | 3.382 | 1 | 1 | 58 |
| GO:0005840 | ribosome | 9.32e-02 | 1.00e+00 | 3.357 | 1 | 2 | 59 |
| GO:0045216 | cell-cell junction organization | 9.32e-02 | 1.00e+00 | 3.357 | 1 | 2 | 59 |
| GO:0005643 | nuclear pore | 9.32e-02 | 1.00e+00 | 3.357 | 1 | 4 | 59 |
| GO:0031966 | mitochondrial membrane | 9.32e-02 | 1.00e+00 | 3.357 | 1 | 1 | 59 |
| GO:0019901 | protein kinase binding | 9.76e-02 | 1.00e+00 | 1.918 | 2 | 21 | 320 |
| GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 9.77e-02 | 1.00e+00 | 3.285 | 1 | 2 | 62 |
| GO:0007411 | axon guidance | 1.01e-01 | 1.00e+00 | 1.886 | 2 | 9 | 327 |
| GO:0003682 | chromatin binding | 1.05e-01 | 1.00e+00 | 1.856 | 2 | 12 | 334 |
| GO:0030141 | secretory granule | 1.05e-01 | 1.00e+00 | 3.173 | 1 | 2 | 67 |
| GO:0003697 | single-stranded DNA binding | 1.08e-01 | 1.00e+00 | 3.131 | 1 | 9 | 69 |
| GO:0005813 | centrosome | 1.08e-01 | 1.00e+00 | 1.834 | 2 | 12 | 339 |
| GO:0034329 | cell junction assembly | 1.11e-01 | 1.00e+00 | 3.090 | 1 | 1 | 71 |
| GO:0032587 | ruffle membrane | 1.13e-01 | 1.00e+00 | 3.070 | 1 | 4 | 72 |
| GO:0032355 | response to estradiol | 1.14e-01 | 1.00e+00 | 3.050 | 1 | 5 | 73 |
| GO:0003729 | mRNA binding | 1.14e-01 | 1.00e+00 | 3.050 | 1 | 4 | 73 |
| GO:0000785 | chromatin | 1.14e-01 | 1.00e+00 | 3.050 | 1 | 5 | 73 |
| GO:0002020 | protease binding | 1.16e-01 | 1.00e+00 | 3.030 | 1 | 4 | 74 |
| GO:0003723 | RNA binding | 1.16e-01 | 1.00e+00 | 1.768 | 2 | 19 | 355 |
| GO:0006874 | cellular calcium ion homeostasis | 1.18e-01 | 1.00e+00 | 2.992 | 1 | 1 | 76 |
| GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 1.20e-01 | 1.00e+00 | 2.973 | 1 | 5 | 77 |
| GO:0008584 | male gonad development | 1.20e-01 | 1.00e+00 | 2.973 | 1 | 2 | 77 |
| GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 1.20e-01 | 1.00e+00 | 2.973 | 1 | 6 | 77 |
| GO:0007229 | integrin-mediated signaling pathway | 1.21e-01 | 1.00e+00 | 2.954 | 1 | 2 | 78 |
| GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 1.24e-01 | 1.00e+00 | 2.918 | 1 | 2 | 80 |
| GO:0007565 | female pregnancy | 1.24e-01 | 1.00e+00 | 2.918 | 1 | 2 | 80 |
| GO:0030968 | endoplasmic reticulum unfolded protein response | 1.26e-01 | 1.00e+00 | 2.900 | 1 | 2 | 81 |
| GO:0001889 | liver development | 1.27e-01 | 1.00e+00 | 2.882 | 1 | 3 | 82 |
| GO:0007155 | cell adhesion | 1.32e-01 | 1.00e+00 | 1.655 | 2 | 8 | 384 |
| GO:0007160 | cell-matrix adhesion | 1.36e-01 | 1.00e+00 | 2.780 | 1 | 3 | 88 |
| GO:0008284 | positive regulation of cell proliferation | 1.37e-01 | 1.00e+00 | 1.625 | 2 | 8 | 392 |
| GO:0018279 | protein N-linked glycosylation via asparagine | 1.40e-01 | 1.00e+00 | 2.732 | 1 | 2 | 91 |
| GO:0016363 | nuclear matrix | 1.42e-01 | 1.00e+00 | 2.716 | 1 | 11 | 92 |
| GO:0042470 | melanosome | 1.42e-01 | 1.00e+00 | 2.716 | 1 | 10 | 92 |
| GO:0006928 | cellular component movement | 1.42e-01 | 1.00e+00 | 2.716 | 1 | 7 | 92 |
| GO:0005178 | integrin binding | 1.49e-01 | 1.00e+00 | 2.640 | 1 | 2 | 97 |
| GO:0070588 | calcium ion transmembrane transport | 1.61e-01 | 1.00e+00 | 2.512 | 1 | 1 | 106 |
| GO:0014069 | postsynaptic density | 1.61e-01 | 1.00e+00 | 2.512 | 1 | 1 | 106 |
| GO:0050900 | leukocyte migration | 1.68e-01 | 1.00e+00 | 2.445 | 1 | 1 | 111 |
| GO:0015630 | microtubule cytoskeleton | 1.70e-01 | 1.00e+00 | 2.432 | 1 | 5 | 112 |
| GO:0005635 | nuclear envelope | 1.75e-01 | 1.00e+00 | 2.382 | 1 | 6 | 116 |
| GO:0072562 | blood microparticle | 1.75e-01 | 1.00e+00 | 2.382 | 1 | 4 | 116 |
| GO:0044237 | cellular metabolic process | 1.78e-01 | 1.00e+00 | 2.357 | 1 | 3 | 118 |
| GO:0007596 | blood coagulation | 1.78e-01 | 1.00e+00 | 1.382 | 2 | 14 | 464 |
| GO:0006325 | chromatin organization | 1.85e-01 | 1.00e+00 | 2.297 | 1 | 4 | 123 |
| GO:0055114 | oxidation-reduction process | 1.88e-01 | 1.00e+00 | 1.330 | 2 | 11 | 481 |
| GO:0006260 | DNA replication | 1.88e-01 | 1.00e+00 | 2.274 | 1 | 12 | 125 |
| GO:0007050 | cell cycle arrest | 1.89e-01 | 1.00e+00 | 2.262 | 1 | 7 | 126 |
| GO:0005506 | iron ion binding | 1.90e-01 | 1.00e+00 | 2.251 | 1 | 3 | 127 |
| GO:0006511 | ubiquitin-dependent protein catabolic process | 1.90e-01 | 1.00e+00 | 2.251 | 1 | 5 | 127 |
| GO:0045893 | positive regulation of transcription, DNA-templated | 1.92e-01 | 1.00e+00 | 1.312 | 2 | 17 | 487 |
| GO:0030335 | positive regulation of cell migration | 1.94e-01 | 1.00e+00 | 2.217 | 1 | 6 | 130 |
| GO:0042802 | identical protein binding | 1.94e-01 | 1.00e+00 | 1.300 | 2 | 18 | 491 |
| GO:0016477 | cell migration | 1.96e-01 | 1.00e+00 | 2.206 | 1 | 6 | 131 |
| GO:0000086 | G2/M transition of mitotic cell cycle | 2.04e-01 | 1.00e+00 | 2.142 | 1 | 7 | 137 |
| GO:0007507 | heart development | 2.09e-01 | 1.00e+00 | 2.100 | 1 | 5 | 141 |
| GO:0061024 | membrane organization | 2.16e-01 | 1.00e+00 | 2.050 | 1 | 5 | 146 |
| GO:0030246 | carbohydrate binding | 2.22e-01 | 1.00e+00 | 2.001 | 1 | 1 | 151 |
| GO:0005788 | endoplasmic reticulum lumen | 2.30e-01 | 1.00e+00 | 1.945 | 1 | 1 | 157 |
| GO:0005769 | early endosome | 2.31e-01 | 1.00e+00 | 1.936 | 1 | 2 | 158 |
| GO:0046777 | protein autophosphorylation | 2.31e-01 | 1.00e+00 | 1.936 | 1 | 3 | 158 |
| GO:0005615 | extracellular space | 2.32e-01 | 1.00e+00 | 0.844 | 3 | 17 | 1010 |
| GO:0006397 | mRNA processing | 2.45e-01 | 1.00e+00 | 1.839 | 1 | 3 | 169 |
| GO:0005739 | mitochondrion | 2.48e-01 | 1.00e+00 | 0.794 | 3 | 24 | 1046 |
| GO:0030424 | axon | 2.49e-01 | 1.00e+00 | 1.813 | 1 | 3 | 172 |
| GO:0016607 | nuclear speck | 2.53e-01 | 1.00e+00 | 1.788 | 1 | 4 | 175 |
| GO:0004672 | protein kinase activity | 2.56e-01 | 1.00e+00 | 1.764 | 1 | 2 | 178 |
| GO:0031625 | ubiquitin protein ligase binding | 2.59e-01 | 1.00e+00 | 1.748 | 1 | 13 | 180 |
| GO:0019904 | protein domain specific binding | 2.60e-01 | 1.00e+00 | 1.740 | 1 | 6 | 181 |
| GO:0043687 | post-translational protein modification | 2.60e-01 | 1.00e+00 | 1.740 | 1 | 4 | 181 |
| GO:0005578 | proteinaceous extracellular matrix | 2.63e-01 | 1.00e+00 | 1.724 | 1 | 1 | 183 |
| GO:0001525 | angiogenesis | 2.83e-01 | 1.00e+00 | 1.596 | 1 | 4 | 200 |
| GO:0005622 | intracellular | 3.14e-01 | 1.00e+00 | 1.419 | 1 | 5 | 226 |
| GO:0007067 | mitotic nuclear division | 3.20e-01 | 1.00e+00 | 1.388 | 1 | 13 | 231 |
| GO:0003713 | transcription coactivator activity | 3.29e-01 | 1.00e+00 | 1.339 | 1 | 10 | 239 |
| GO:0000166 | nucleotide binding | 3.65e-01 | 1.00e+00 | 1.152 | 1 | 6 | 272 |
| GO:0005975 | carbohydrate metabolic process | 3.67e-01 | 1.00e+00 | 1.142 | 1 | 5 | 274 |
| GO:0043065 | positive regulation of apoptotic process | 3.67e-01 | 1.00e+00 | 1.142 | 1 | 8 | 274 |
| GO:0007283 | spermatogenesis | 3.69e-01 | 1.00e+00 | 1.131 | 1 | 6 | 276 |
| GO:0042493 | response to drug | 3.82e-01 | 1.00e+00 | 1.070 | 1 | 11 | 288 |
| GO:0019899 | enzyme binding | 3.82e-01 | 1.00e+00 | 1.070 | 1 | 11 | 288 |
| GO:0007264 | small GTPase mediated signal transduction | 3.84e-01 | 1.00e+00 | 1.060 | 1 | 3 | 290 |
| GO:0030198 | extracellular matrix organization | 3.89e-01 | 1.00e+00 | 1.035 | 1 | 3 | 295 |
| GO:0005743 | mitochondrial inner membrane | 3.94e-01 | 1.00e+00 | 1.011 | 1 | 5 | 300 |
| GO:0005856 | cytoskeleton | 4.05e-01 | 1.00e+00 | 0.959 | 1 | 8 | 311 |
| GO:0006508 | proteolysis | 4.97e-01 | 1.00e+00 | 0.560 | 1 | 9 | 410 |
| GO:0045892 | negative regulation of transcription, DNA-templated | 5.09e-01 | 1.00e+00 | 0.512 | 1 | 14 | 424 |
| GO:0008270 | zinc ion binding | 5.35e-01 | 1.00e+00 | 0.180 | 2 | 12 | 1067 |
| GO:0048471 | perinuclear region of cytoplasm | 5.85e-01 | 1.00e+00 | 0.209 | 1 | 12 | 523 |
| GO:0005509 | calcium ion binding | 6.30e-01 | 1.00e+00 | 0.037 | 1 | 8 | 589 |
| GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 6.30e-01 | 1.00e+00 | 0.037 | 1 | 12 | 589 |
| GO:0005783 | endoplasmic reticulum | 6.43e-01 | 1.00e+00 | -0.013 | 1 | 9 | 610 |
| GO:0045087 | innate immune response | 6.46e-01 | 1.00e+00 | -0.027 | 1 | 20 | 616 |
| GO:0005794 | Golgi apparatus | 6.67e-01 | 1.00e+00 | -0.105 | 1 | 14 | 650 |
| GO:0046872 | metal ion binding | 7.11e-01 | 1.00e+00 | -0.277 | 2 | 24 | 1465 |
| GO:0003700 | sequence-specific DNA binding transcription factor activity | 7.19e-01 | 1.00e+00 | -0.307 | 1 | 11 | 748 |
| GO:0007165 | signal transduction | 8.02e-01 | 1.00e+00 | -0.652 | 1 | 17 | 950 |
| GO:0005887 | integral component of plasma membrane | 8.06e-01 | 1.00e+00 | -0.669 | 1 | 7 | 961 |
| GO:0005576 | extracellular region | 8.34e-01 | 1.00e+00 | -0.795 | 1 | 9 | 1049 |
| GO:0006355 | regulation of transcription, DNA-templated | 8.49e-01 | 1.00e+00 | -0.869 | 1 | 17 | 1104 |
| GO:0005886 | plasma membrane | 8.72e-01 | 1.00e+00 | -0.644 | 3 | 38 | 2834 |
| GO:0003677 | DNA binding | 9.03e-01 | 1.00e+00 | -1.160 | 1 | 26 | 1351 |